p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection (Q43580782)

24 November 2017

title

p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection (English)

1 reference

24 November 2017

main subject

hepatocellular carcinoma

1 reference

Xiao-Min Wang

1 reference

24 November 2017

Lian-Yue Yang

1 reference

24 November 2017

Lei Guo

1 reference

24 November 2017

Chun Fan

1 reference

24 November 2017

Fan Wu

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

24 November 2017

1 reference

24 November 2017

volume

115

1 reference

24 November 2017

1 reference

24 November 2017

page(s)

4554-4563

1 reference

Global cancer statistics, 2002

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Progress in surgical treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Biology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Proteomics of proteasome complexes and ubiquitinated proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Proteasome inhibitors in cancer therapy: lessons from the first decade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

The proteasome: a novel target for anticancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

The proteasome: a worthwhile target for the treatment of solid tumours?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

p53 ubiquitination: Mdm2 and beyond

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Decreased expression of methyl methansulfonate and ultraviolet-sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Anthony Dipple Carcinogenesis Award. p53 from pathway to therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

The P53 pathway: what questions remain to be explored?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Wild-type p53: tumors can't stand it.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Living with p53, dying of p53.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Inactivation of the p53 pathway in retinoblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

The p53 pathway: positive and negative feedback loops

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

The ubiquitin ligase COP1 is a critical negative regulator of p53

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24494

7 January 2021

Identifiers

DOI

10.1002/CNCR.24494

1 reference

24 November 2017

1 reference